Minimally invasive surgical (MIS) technology ecosystem is one of the foremost fields in the healthcare domain, which witnessed a significant impact due to the outbreak of COVID-19. Analyzing the performance and prospects of different companies offering MIS technologies, in the past decade (2010-2019), the year 2020 was expected to be the head start for the ubiquitous incorporation of MIS technology and rise of next-generation MIS technologies such as hand-held robotic MIS equipment, miniaturized surgical robotics, and autonomous surgical robotics, among others. However, what started as an outbreak in China at the end of 2019, has completely shifted the course of the MIS technology ecosystem and resulted in a massive impact on MIS technology ecosystem.
Globally, the exponential rise in the number of COVID-19 cases has significantly increased the pressure on the healthcare ecosystem, specifically on the healthcare providers. Due to the roll-out of regulations that recommended de-prioritization of elective surgeries, resulted in a massive decrease in every-day MIS procedures and consequentially impacted the global revenue of the MIS technology ecosystem.
In the pre-COVID-19 scenario, it was estimated that the year 2020 would witness an annual MIS procedure volume of 138.5 million and, similarly 2021, would witness 144.9 million MIS procedures. However, since in most of the countries, hospitals have been advised to deprioritize elective surgeries, the global MIS procedure volume is expected to be slashed by 40%, to drop to 83.1 million in 2020.
To gauge the impact of COVID-19 on the MIS technology ecosystem and to ideate strategies to overcome the same, BIS Research is conducting a webinar, Impact of COVID-19 on Minimally Invasive Surgical Technology Ecosystem, on Thursday 16th July 2020 at 10:30 AM PST - 11:30 AM PST, with guest speakers Mr. Devon Bream - Global Vice President Endoscopy, Fujifilm Medical, Mr. Mohan Nathan - VP, Global Clinical Marketing, TransEnterix Surgical, Inc. and Timothy Lantz – President, Caresyntax, Inc
Why Attend the Webinar?
To gauge the impact of COVID-19 on MIS Ecosystem
To understand how different technological powerhouse countries such as the U.S., Germany, the U.K. France, Spain, China, and Japan are handling this crisis
To estimate the probable recovery time required to overcome this current crisis
To ideate strategies to be incorporated to minimize the impact of COVID-19
Who Should Attend this Webinar?
Conventional MIS companies
Surgical robotic companies
Surgery simulation system companies
Hospital administration and business management professionals
Venture capitalist firms
Attendees’ Take Home
Live Q&A with Guest Speakers
Free Analyst Note titled “Implications of COVID-19 on Minimally Invasive Surgical Technology Market – Current & Future JUNE 2020”
Devon Bream - Global Vice President Endoscopy, Fujifilm Medical
Global healthcare leader renowned for his business strategies.
Holds more than 25 years of industry experience in the field of minimally invasive surgery technologies.
Previously associated with world-class organizations such as Karl Storz Endoscopy, STERIS Corporation, and Olympus Corporation.
Part of Fellow of American College of Healthcare Executives.
Mohan Nathan - VP, Global Clinical Marketing, TransEnterix Surgical, Inc.
Expert and holds more than 12 years of industry experience in the field of surgical robotics.
Previously associated with companies such as Intuitive Surgical, Inc. and Johnson & Johnson (LifeScan, Inc.)
Influential thought leader renowned for his public engagements with academicians.
Timothy Lantz – President, Caresyntax, Inc
Holds more than 20 years of leadership experience in healthcare finance, operations and technology.
Currently serving on the Board of Directors of First Stage.
Previously associated with the International Performance Management Institute’s Healthcare Finance Advisory Committee.